Delivery Order SPE2DB24D9313-SPE2DB25FFFHQ

Award Date 1/30/25
Potential Completion Date 1/31/25
Potential Value $8.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a $4,169.59 firm fixed-price delivery order for the pharmaceutical product XTANDI 40 MG TABLET 120S. The contract has an ultimate completion date of January 15, 2025. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $4,169.59 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of the prescription drug XTANDI (80 mg tablet, 60-count) and has an ultimate completion date of October 23, 2024. This award is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the DLA valued at...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, worth up to $4,169.59, is for the delivery of XTANDI 40 MG TABLET 120S, with an ultimate completion date of April 5, 2024. This award is part of a larger indefinite delivery contract, SPE2DB, that DMS Pharmaceutical Group holds with the DLA, valued at...
The U.S. government's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $4,169.59 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, with an ultimate completion date of September 6, 2024, is for the supply of XTANDI 40 MG TABLET 120S. This award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $8,622.72, is for the delivery of XTANDI 40 MG CAPSULE 120S to the DLA. This is a firm fixed-price delivery order contract with an ultimate completion date of April 22, 2024. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $8,339.18, is a firm fixed-price delivery order for the supply of XTANDI 40 MG TABLET 120S, a specialized pharmaceutical product. The contract is part of a larger Indefinite Delivery Contract (IDC) awarded to DMS Pharmaceutical Group Inc. under the DLA's SPE2DB program, which...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $8,622.72 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 120 units of the pharmaceutical product XTANDI 40 MG CAPSULE. This order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA's Medical Supply Chain division, valued at up to $499,999,999. The IDC runs through December 31, 2025...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,622.72 firm fixed-price delivery order is for the supply of XTANDI 40 MG CAPSULE 120S, a specialized pharmaceutical product. The contract has an ultimate completion date of December 17, 2024. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $12,508.77 firm fixed-price delivery order is for the supply of XTANDI 40 MG TABLET 120S, with an ultimate completion date of November 25, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 between DMS Pharmaceutical Group and the DLA, which...
This federal contract award, valued at $8,339.18, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the provision of XTANDI 80 MG TABLET 60S, a specialized pharmaceutical product. DMS Pharmaceutical Group Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
  • SPE2DB24D9313
    Indefinite Delivery Contract
  • SPE2DB24D9313-SPE2DB25FFFHQ
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order valued at $8,339.18 for the supply of XTANDI 40 MG TABLET 120S, a prescription medication. The contract has a firm fixed-price pricing type and an ultimate completion date of January 31, 2025.

DMS Pharmaceutical Group Inc. also holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The contract covers an extensive portfolio of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables.

Generated 5/1/25, 10:03 AM